Schisandrin has significant antioxidant and anti-inflammatory properties, particularly in PD models, where it reduced oxidative stress and inflammation [55]
As with any medical decision, the right choice starts with informed discussion
doi:10.1038/s41598-022-26927-z 4
Phase 2 data published in the New England Journal of Medicine in 2023 showed that the 12 mg dose produced a mean 24.2% reduction in body weight at 48 weeks in adults with obesity, which is numerically larger than anything reported for a single agent in a controlled trial to that point
Though the insurance coverage of GLP-1s remains spotty, Novo and Eli Lilly (makers of tirzepatide, the other major GLP-1 on the market) have steadily lowered the out-of-pocket cost of their drugs, particularly this year
The thigh's anatomical consistency means fewer week-to-week fluctuations in medication levels, which translates to more reliable weight loss outcomes in long-term studies